Key result
Dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics, supporting its role as a myocardial depressant factor in cardiogenic shock.
Key points are not available for this paper at this time.
Design
Editorial
Answers are grounded in this paper and cite their sources.
This is an editorial discussing the role of dipeptidyl peptidase 3 as a biomarker and potential therapeutic target in cardiogenic shock.
This article refers to 'Circulating dipeptidyl peptidase 3 is a myocardial depressant factor: dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics' by B.
No takes yet. Share an insight, caveat, or question.
Magliocca et al. (2019) studied this question. Dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics, supporting its role as a myocardial depressant factor in cardiogenic shock.
Synapse has enriched 10 related papers. Consider them for comparative context: